Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Mach7 Technologies's Enterprise Value is A$141.18 Mil.
Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil. Therefore, Mach7 Technologies's EV-to-EBIT ratio for today is -6.55.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Mach7 Technologies's Enterprise Value is A$141.18 Mil.
Mach7 Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-13.85 Mil. Therefore, Mach7 Technologies's EV-to-EBITDA ratio for today is -10.19.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Mach7 Technologies's Enterprise Value is A$141.18 Mil.
Mach7 Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$17.18 Mil. Therefore, Mach7 Technologies's EV-to-Revenue ratio for today is 8.22.
Mach7 Technologies Enterprise Value Historical Data
The historical data trend for Mach7 Technologies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mach7 Technologies's Enterprise Value
For the Health Information Services subindustry, Mach7 Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mach7 Technologies's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Mach7 Technologies's Enterprise Value falls into.
Mach7 Technologies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Mach7 Technologies's Enterprise Value for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mach7 Technologies (ASX:M7T) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Mach7 Technologies's current Enterprise Value is A$141.18 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Mach7 Technologies's current Enterprise Value is A$141.18 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$-13.85 Mil.
Mach7 Technologies's current Enterprise Value is A$141.18 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Mach7 Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$17.18 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mach7 Technologies Enterprise Value Related Terms
Thank you for viewing the detailed overview of Mach7 Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:M7T has been successfully added to your 